Cargando…

OR03-1 The Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis and Osteoarthritis

Abaloparatide (ABL) is a novel, selective activator of the PTH1 receptor signaling pathway. In the 18-month Phase 3 ACTIVE study in women with postmenopausal osteoporosis (OP) (NCT01343004), ABL significantly increased bone mineral density (BMD), and decreased the risk of new vertebral (VF), nonvert...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lane, Nancy, Mitlak, Bruce, Weiss, Richard, Wang, Yamei, Valenzuela, Guillermo, Bilezikian, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Bone and Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554836/ http://dx.doi.org/10.1210/js.2019-OR03-1

Ejemplares similares

SAT-519 Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in a Subset of Younger Postmenopausal Women with Osteoporosis at High Risk for Fracture Representative of Covered Commercial Insurance Enrollees
por: Saag, Kenneth, et al.
Publicado: (2019)

OR03-2 Different Effects of Abaloparatide and h-PTH(1-34) on Osteoclastogenesis and Bone Resorption
por: Arlt, Heike, et al.
Publicado: (2019)

SUN-385 Differential Effects of Abaloparatide and Teriparatide on Hip Cortical Volumetric BMD by DXA-Based 3d Modeling
por: Winzenrieth, Renaud, et al.
Publicado: (2020)

PSAT156 Abaloparatide Implementation and Follow-Up: Real-World Results of a Pharmacist-Run Anabolic Osteoporosis Clinic
por: Arceri, Veronica, et al.
Publicado: (2022)

SUN-377 Efficacy of Low Dose Denosumab in Maintaining Bone Mineral Density in Postmenopausal Women with Osteoporosis: A Real World, Prospective Observational Study
por: Khan, Aliya Aziz, et al.
Publicado: (2020)

SUN-335 Abaloparatide Prevents Unloading-Induced Bone Loss in Adult Rats
por: Teguh, Dian A, et al.
Publicado: (2020)

Impact of Thyroid Disease on Bone Mineral Density Preservation in Patients With Osteoporosis and Idiopathic Hypercalciuria
por: Chu, James W
Publicado: (2021)

OR01-5 Transition From Low Dose Denosumab 30mg to IV Zoledronic Acid: Effect on Bone Mineral Density in Postmenopausal Women with Osteoporosis: A Prospective Observational Study
por: Ibrahim, Quazi, et al.
Publicado: (2022)

Efficacy of Low Dose Denosumab in Maintaining Bone Mineral Density in Postmenopausal Women With Osteoporosis Switching From 60mg to 30mg 6 Monthly: A Real World, Prospective Observational Study
por: Khan, Aliya, et al.
Publicado: (2021)

MON-365 Novel Use of Abaloparatide to Augment Spinal Fusion in Patient Undergoing Cervicothoracic Revision Surgery
por: Parikh, Sahil, et al.
Publicado: (2020)

MON-373 Low Bone Mineral Density Does Not Equal Osteoporosis: The Finding of XLHR with a Novel Phex Mutation
por: Tran, Kelvin, et al.
Publicado: (2020)

MON-LB71 Adult Hypophosphatasia and Postmenopausal Osteoporosis: A Challenging Case
por: Abramof-Ness, Rosane, et al.
Publicado: (2020)

OR21-4 Comparison of the Effects of PTH (1-34), PTHrP (1-36) and Abaloparatide (ABL) on the Murine Osteoblast Transcriptome
por: He, Zhiming, et al.
Publicado: (2022)

SAT-535 Association Between Adiponectin and Bone Mineral Density in Mexican Postmenopausal Women with Normal Glucose Tolerance and Type 2 Diabetes Mellitus
por: Tenorio-Rojo, Andrea, et al.
Publicado: (2019)

OR13-06 Romosozumab After Denosumab Improves Lumbar Spine Bone Mineral Density And Microarchitecture Greater Than Denosumab Continuation In Postmenopausal Women
por: Hong, Namki, et al.
Publicado: (2023)

SUN-386 Treatment Outcomes of Intravenous Zoledronic Acid vs Oral Alendronate in Postmenopausal Women with Osteoporosis
por: Pyone, Zar Chi, et al.
Publicado: (2020)

SUN-389 Trends in Osteoporosis Treatment Uptake and Persistence Among Postmenopausal Women in the U.S., 2010–2015
por: Kim, Min, et al.
Publicado: (2020)

SUN-395 Pelvic Bone Density Is Lower Than Bone Density of Hip and Femoral Neck in Postmenopausal Women
por: Mohseni, Mahshid, et al.
Publicado: (2020)

SUN-LB65 Circulating Micrornas Linked to Bone Metabolism Are Affected by Sequential Anti Osteoporotic Treatment in Postmenopausal Osteoporosis
por: Yavropoulou, Maria, et al.
Publicado: (2020)

ODP119 Raloxifene use after denosumab discontinuation partially attenuates bone loss in the lumbar spine in postmenopausal osteoporosis
por: Hone, Namki, et al.
Publicado: (2022)

MON-378 Efficacy and Safety of Romosozumab vs Alendronate Is Similar Across Different Levels of Renal Function Among Postmenopausal Women with Osteoporosis
por: Miller, Paul, et al.
Publicado: (2020)

The Impact of Glucose Tolerance States on Bone Mineral Density and Fracture Rate
por: Villacreses, Maria Chang, et al.
Publicado: (2021)

OR13-05 Romosozumab Treatment Lowers the Incidence of New Vertebral Fractures Across All Fracture Severity Grades Among Postmenopausal Women with Osteoporosis
por: Feldman, Robert, et al.
Publicado: (2020)

OR13-4 Bone Mineral Density in Transgender Youth on Gender Affirming Therapies
por: Ma, Nina, et al.
Publicado: (2022)

THU451 Low Bone Mineral Density In A Patient With Thalassemia Minor
por: Woron, Felicia, et al.
Publicado: (2023)

An Observational Study to Assess the Safety and Efficacy on Quality of Life and Patient Satisfaction With Raloxifene/Cholecalciferol Combination Therapy in Postmenopausal Women Requiring Prevention or Treatment for Osteoporosis
por: Chung, Yoon-Sok, et al.
Publicado: (2021)

THU425 Brief, Low-impact, High-intensity Osteogenic Loading Training Utilizing Proprietary Osteostrong Devices With Once-A-Week, 10 Minute Treatments Improves Bone Mineral Density In Women With Osteoporosis Of The Lumbar Spine
por: Papadopoulou-Marketou, Nektaria, et al.
Publicado: (2023)

SUN-LB090 Accounting for Skeletal Maturation in the Assessment of Pediatric Bone Mineral Density
por: McCormack, Shana, et al.
Publicado: (2019)

SUN-371 Hyponatremia Correction Normalizes Bone Mineral Density and Bone Fragility in Rats
por: Xu, Qin, et al.
Publicado: (2020)

SUN-392 Bone Mineral Density and Body Mass Index in Men with Cystic Fibrosis
por: Jawahar, Abhinaya, et al.
Publicado: (2020)

Effects of the Rate of Impaired Insulin Secretion on Bone Mineral Density in Type 1 Diabetes
por: Suzuki, Masaki, et al.
Publicado: (2021)

Bone Mineral Density Assessment Following Radiotherapy Related Insufficiency Fractures (RRIFs) of the Pelvis
por: Grigoriadou, Victoria Chatzimavridou, et al.
Publicado: (2021)

MON-496 Bone Mineral Density improvement with Vitamin Dsupplementation in a Case Of Childhood Hypophosphatasia
por: Babar, Ghufran
Publicado: (2019)

SUN-342 Effect of Hyperglycemia on Bone Mineral Density and Fracture in Pre-Liver Transplant Recipients
por: Abate, Ejigayehu G, et al.
Publicado: (2020)

MON-387 Association Between Vitamin D Level and Bone Mineral Density in Korean Adolescents
por: Song, Kyungchul, et al.
Publicado: (2020)

Low Bone Mineral Density and Recurrent Fractures During and After Pregnancy: Dilemma of an Overlooked Diagnosis
por: Jodeh, Wade S, et al.
Publicado: (2021)

ODP105 Long-Term Bone Mineral Density Changes for Amputees Following Transcutaneous Osseointegration
por: Vrazas, Elisabeth, et al.
Publicado: (2022)

OR01-3 Lack of Bone Mineral Density Testing in Men with Hypogonadism: A Clinical Conundrum
por: Pantalone, Kevin, et al.
Publicado: (2022)

THU465 Significant Improvement In Bone Mineral Density Following Treatment For Tumor Induced Osteomalacia
por: McHan, Lara C, et al.
Publicado: (2023)

MON-515 Lack Of Association Between Bone Mineral Density And Breast Arterial Calcification: The Minerva Study
por: Iribarren, Carlos, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oipiahdnuv6krabe2ofrk25h01